DIVA Laboratories Ltd (TWO:4153) — Market Cap & Net Worth
Market Cap & Net Worth: DIVA Laboratories Ltd (4153)
DIVA Laboratories Ltd (TWO:4153) has a market capitalization of $58.78 Million (NT$1.87 Billion) as of September 16, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21394 globally and #1287 in its home market, demonstrating a -1.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DIVA Laboratories Ltd's stock price NT$31.80 by its total outstanding shares 58668000 (58.67 Million). Also see DIVA Laboratories Ltd asset portfolio for a full breakdown of the balance sheet.
DIVA Laboratories Ltd Market Cap History: 2015 to 2026
DIVA Laboratories Ltd's market capitalization history from 2015 to 2026. Data shows change from $114.25 Million to $58.78 Million (-7.37% CAGR). Also see DIVA Laboratories Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
DIVA Laboratories Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DIVA Laboratories Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 4153 share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.07x
DIVA Laboratories Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.71x
DIVA Laboratories Ltd's market cap is 0.71 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $60.71 Million | $857.00 Million | -$267.15 Million | 0.07x | N/A |
| 2018 | $59.28 Million | $650.13 Million | $52.15 Million | 0.09x | 1.14x |
| 2019 | $58.56 Million | $716.17 Million | $56.04 Million | 0.08x | 1.04x |
| 2020 | $43.66 Million | $736.92 Million | $17.42 Million | 0.06x | 2.51x |
| 2021 | $47.66 Million | $712.23 Million | $21.86 Million | 0.07x | 2.18x |
| 2022 | $73.16 Million | $949.20 Million | $49.66 Million | 0.08x | 1.47x |
| 2023 | $68.02 Million | $893.84 Million | $73.62 Million | 0.08x | 0.92x |
| 2024 | $70.70 Million | $862.32 Million | $93.66 Million | 0.08x | 0.75x |
| 2025 | $64.51 Million | $868.84 Million | $90.54 Million | 0.07x | 0.71x |
Competitor Companies of 4153 by Market Capitalization
Companies near DIVA Laboratories Ltd in the global market cap rankings as of September 16, 2026. Review DIVA Laboratories Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to DIVA Laboratories Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
DIVA Laboratories Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, DIVA Laboratories Ltd's market cap moved from $114.25 Million to $ 58.78 Million, with a yearly change of -7.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$58.78 Million | -8.88% |
| 2025 | NT$64.51 Million | -8.76% |
| 2024 | NT$70.70 Million | +3.94% |
| 2023 | NT$68.02 Million | -7.03% |
| 2022 | NT$73.16 Million | +53.52% |
| 2021 | NT$47.66 Million | +9.15% |
| 2020 | NT$43.66 Million | -25.44% |
| 2019 | NT$58.56 Million | -1.22% |
| 2018 | NT$59.28 Million | -2.35% |
| 2017 | NT$60.71 Million | -10.00% |
| 2016 | NT$67.45 Million | -40.96% |
| 2015 | NT$114.25 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of DIVA Laboratories Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $58.78 Million USD |
| MoneyControl | $58.78 Million USD |
| MarketWatch | $58.78 Million USD |
| marketcap.company | $58.78 Million USD |
| Reuters | $58.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DIVA Laboratories Ltd
DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is he… Read more